Best Biotechnology Stocks

Compare the best biotech stocks to buy today.

Biotech stocks are investments in companies that develop products and technologies based on biological research, primarily aimed at advancing healthcare, agriculture, and environmental solutions. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

This list includes the largest market-cap stocks in the biotechnology field. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	PE Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$196.53 +0.2%	58.32	$347.05 billion	3.60 million	5.51 million
TMO Thermo Fisher Scientific	$610.17 -0.7%	39.14	$233.08 billion	964,949	1.54 million	Analyst Revision
DHR Danaher	$271.15 -0.2%	45.96	$200.84 billion	1.46 million	2.84 million	Short Interest ↓
VRTX Vertex Pharmaceuticals	$486.11 -0.3%	31.55	$125.46 billion	810,004	1.21 million	Positive News
GSK GSK	$41.85 +0.6%	15.16	$86.73 billion	2.41 million	3.55 million
COR Cencora	$239.27 +0.4%	26.18	$47.72 billion	775,124	1.37 million	Analyst Forecast Positive News
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
TAK Takeda Pharmaceutical	$14.94 +1.2%	27.16	$47.28 billion	2.23 million	1.89 million
IQV IQVIA	$247.00 +0.0%	33.74	$44.99 billion	717,431	1.07 million	Analyst Upgrade
CTSH Cognizant Technology Solutions	$76.62 +1.5%	18.42	$38.10 billion	3.23 million	4.09 million	Positive News
ALNY Alnylam Pharmaceuticals	$279.17 -0.6%	N/A	$35.31 billion	663,683	886,836	Analyst Forecast
MRNA Moderna	$86.65 -0.3%	N/A	$33.21 billion	3.15 million	4.10 million
VEEV Veeva Systems	$201.30 +3.9%	59.38	$32.54 billion	1.13 million	958,579	Upcoming Earnings Insider Selling
ARGX argenx	$525.50 +0.3%	N/A	$31.23 billion	260,299	328,950
ICLR ICON Public	$323.13 -0.3%	39.31	$26.66 billion	195,585	560,782
BNTX BioNTech	$88.99 +0.5%	177.98	$21.16 billion	517,722	704,251	Analyst Forecast Short Interest ↓ Analyst Revision
ILMN Illumina	$132.62 +0.1%	N/A	$21.13 billion	1.62 million	2.12 million	Analyst Forecast
DNA Ginkgo Bioworks	$9.28 +20.4%	N/A	$20.63 billion	3.44 million	1.06 million	Gap Up High Trading Volume
LH Laboratory Co. of America	$228.80 +1.4%	46.04	$19.29 billion	301,940	709,542	Analyst Upgrade Insider Selling Short Interest ↓
RPRX Royalty Pharma	$27.60 +1.2%	20.60	$16.12 billion	3.93 million	3.11 million	Positive News
UTHR United Therapeutics	$351.61 +1.4%	16.62	$15.64 billion	669,731	498,616	Analyst Forecast Insider Selling Positive News
RVTY Revvity	$120.73 +1.0%	99.78	$14.90 billion	460,868	862,344	Analyst Revision
SUZ Suzano	$10.35 +1.1%	7.39	$13.70 billion	2.24 million	1.98 million
MEDP Medpace	$395.71 +1.6%	40.34	$12.26 billion	122,667	244,742
CTLT Catalent	$59.40 -0.1%	N/A	$10.75 billion	1.80 million	2.16 million	Positive News
CRL Charles River Laboratories International	$204.26 +0.9%	24.03	$10.43 billion	563,193	589,324	Analyst Upgrade
LEGN Legend Biotech	$56.46 -1.1%	N/A	$10.29 billion	613,531	1.06 million
FN Fabrinet	$273.50 +2.1%	36.32	$9.89 billion	707,849	443,599	Earnings Report Analyst Forecast
BIO.B Bio-Rad Laboratories	$320.63 -1.9%	N/A	$9.15 billion	3	1,083
PCVX Vaxcyte	$79.82 +1.0%	N/A	$8.60 billion	304,261	769,029	Gap Up
IBB iShares Biotechnology ETF	$148.15 +0.5%	N/A	$7.97 billion	751,839	1.58 million	Options Volume
KRYS Krystal Biotech	$201.63 +1.3%	107.82	$5.76 billion	210,148	368,266
DYN Dyne Therapeutics	$47.04 +0.5%	N/A	$4.11 billion	962,379	1.57 million	Gap Up
TGTX TG Therapeutics	$25.07 +1.5%	109.00	$3.87 billion	2.79 million	3.70 million
LITE Lumentum	$56.39 +0.5%	N/A	$3.81 billion	1.62 million	1.40 million
FOLD Amicus Therapeutics	$12.09 +1.4%	N/A	$3.58 billion	2.36 million	2.86 million
DNLI Denali Therapeutics	$25.00 +5.7%	N/A	$3.57 billion	988,378	1.15 million	Gap Up
IOVA Iovance Biotherapeutics	$11.83 +4.8%	N/A	$3.31 billion	6.44 million	7.76 million
OLK Olink Holding AB (publ)	$26.08	N/A	$3.24 billion	1,000	633,228
IBRX ImmunityBio	$4.40 +10.8%	N/A	$3.04 billion	3.62 million	4.96 million	Analyst Forecast
HTGC Hercules Capital	$18.29 +0.1%	8.31	$2.97 billion	1.24 million	992,885
“Generational buying opportunity” - Blackstone (Ad) The decline of Baltimore is symbolic of a financial sea-change that is unfolding all across the country… One that almost nobody else has connected the dots on, but that I believe could either enrich or impoverish millions over the next 12 to 24 months. Go here to watch it now.
SWTX SpringWorks Therapeutics	$39.52 +3.2%	N/A	$2.93 billion	760,538	973,331	Gap Up
APGE Apogee Therapeutics	$48.35 -1.3%	N/A	$2.83 billion	293,113	529,362	Gap Up
TXG 10x Genomics	$23.01 +2.1%	N/A	$2.77 billion	1.07 million	1.67 million
AZTA Azenta	$49.40 -1.0%	N/A	$2.66 billion	597,655	474,906
BE Bloom Energy	$11.59 +0.7%	N/A	$2.63 billion	4.27 million	6.14 million
TWST Twist Bioscience	$44.13 +2.8%	N/A	$2.57 billion	416,857	1.03 million
ODD Oddity Tech	$39.84 -0.4%	33.20	$2.27 billion	562,805	779,071
VERA Vera Therapeutics	$39.94 -0.7%	N/A	$2.19 billion	464,599	971,340
BEAM Beam Therapeutics	$25.49 +3.9%	N/A	$2.10 billion	478,638	1.35 million
SXI Standex International	$176.02 +3.2%	28.48	$2.07 billion	88,967	61,954	Gap Up
FTRE Fortrea	$22.15 -1.2%	N/A	$1.98 billion	938,666	1.20 million	Analyst Forecast
RXRX Recursion Pharmaceuticals	$7.62 +6.4%	N/A	$1.89 billion	5.06 million	5.24 million	Options Volume
IMCR Immunocore	$36.55 -1.5%	N/A	$1.83 billion	262,346	577,735	Short Interest ↓ Positive News
NVAX Novavax	$12.94 -0.6%	N/A	$1.82 billion	4.74 million	11.06 million
RCKT Rocket Pharmaceuticals	$20.00 +3.3%	N/A	$1.82 billion	443,671	751,586	Gap Up
ARVN Arvinas	$25.13 +0.5%	N/A	$1.72 billion	900,595	785,639	Positive News Gap Up
GLPG Galapagos	$25.22 +1.6%	N/A	$1.66 billion	115,158	121,621	News Coverage
BCRX BioCryst Pharmaceuticals	$8.01 +2.4%	N/A	$1.65 billion	1.84 million	3.32 million	Positive News
SAVA Cassava Sciences	$31.21 +4.5%	N/A	$1.50 billion	2.13 million	1.74 million
PHR Phreesia	$24.84 +1.9%	N/A	$1.43 billion	201,482	466,546
OCSL Oaktree Specialty Lending	$17.01 +0.8%	12.69	$1.37 billion	488,939	680,676
TYRA Tyra Biosciences	$22.68 +3.3%	N/A	$1.20 billion	140,107	145,297
VIR Vir Biotechnology	$8.67 -1.6%	N/A	$1.18 billion	637,815	1.06 million	Analyst Forecast
PRTA Prothena	$21.96 +4.7%	N/A	$1.18 billion	527,284	620,802
TPC Tutor Perini	$21.58 -0.8%	N/A	$1.13 billion	251,823	462,872
TRNS Transcat	$122.41 +1.5%	76.99	$1.12 billion	38,874	46,164	Positive News
TNGX Tango Therapeutics	$10.40 -6.4%	N/A	$1.11 billion	638,158	683,810	Insider Selling News Coverage
SANA Sana Biotechnology	$5.30 +5.8%	N/A	$1.11 billion	1.47 million	1.42 million
EVO Evotec	$3.10 -3.1%	N/A	$1.10 billion	104,968	111,053	Gap Down
ALGS Aligos Therapeutics	$13.75 -5.0%	N/A	$1.07 billion	40,742	15,595	Analyst Forecast Stock Split News Coverage High Trading Volume
SYRE Spyre Therapeutics	$26.57 -0.4%	N/A	$1.07 billion	417,491	514,791
ANAB AnaptysBio	$37.78 +4.8%	N/A	$1.03 billion	299,542	337,583
THR Thermon Group	$29.78 +1.4%	19.85	$1.01 billion	71,396	214,811
VRDN Viridian Therapeutics	$15.58 -0.8%	N/A	$995.41 million	596,084	963,673
HQH Abrdn Healthcare Investors	$19.63 +0.2%	N/A	$993.77 million	190,298	167,778	Positive News
COGT Cogent Biosciences	$10.24 +3.2%	N/A	$979.08 million	1.82 million	1.57 million
IMNM Immunome	$15.20 -0.1%	N/A	$911.53 million	359,963	802,389
SLRC SLR Investment	$15.39	8.65	$839.68 million	81,613	160,453	Positive News
WNC Wabash National	$19.07 +2.7%	4.58	$839.08 million	301,205	612,075	Dividend Announcement
DNTH Dianthus Therapeutics	$28.53 -1.6%	N/A	$837.33 million	146,283	191,134
RAPP Rapport Therapeutics	$22.47 +2.1%	N/A	$821.95 million	91,304	172,314	Gap Up
CRGX CARGO Therapeutics	$17.40 +1.5%	N/A	$798.00 million	521,596	244,579	High Trading Volume
FDMT 4D Molecular Therapeutics	$15.19 -0.8%	N/A	$785.37 million	433,568	914,952	Short Interest ↓
ZYME Zymeworks	$11.10 +2.1%	N/A	$784.83 million	435,388	623,770
TCPC BlackRock TCP Capital	$9.08 +0.4%	25.94	$777.16 million	308,486	452,948
SLP Simulations Plus	$37.46 +1.7%	78.04	$749.58 million	128,926	117,509	Positive News
CDMO Avid Bioservices	$11.47 +1.4%	N/A	$729.26 million	458,731	1.17 million	News Coverage Positive News
ABVX ABIVAX Société Anonyme	$11.55 +1.5%	N/A	$726.83 million	58,209	83,727	Positive News
LAB Standard BioTools	$1.94 +4.3%	N/A	$718.62 million	3.16 million	2.71 million	Insider Buying Positive News
WVE Wave Life Sciences	$5.85 -0.7%	N/A	$716.48 million	417,915	841,294	Positive News
“Generational buying opportunity” - Blackstone (Ad) The decline of Baltimore is symbolic of a financial sea-change that is unfolding all across the country… One that almost nobody else has connected the dots on, but that I believe could either enrich or impoverish millions over the next 12 to 24 months. Go here to watch it now.
RVNC Revance Therapeutics	$6.60	N/A	$693.93 million	6.03 million	6.61 million
REPL Replimune Group	$10.27 -2.9%	N/A	$690.73 million	560,684	584,834	News Coverage
ADPT Adaptive Biotechnologies	$4.61 +0.4%	N/A	$679.37 million	1.32 million	1.56 million
IGMS IGM Biosciences	$10.86 +9.3%	N/A	$641.00 million	259,003	312,169	Gap Up
TRDA Entrada Therapeutics	$16.46 -2.8%	26.13	$612.31 million	165,099	95,881	Gap Up
RGNX REGENXBIO	$12.21 +2.9%	N/A	$605.43 million	355,163	511,085	Positive News
CELC Celcuity	$16.99 -0.3%	N/A	$596.37 million	228,212	275,794
JTEK JPMorgan U.S. Tech Leaders ETF	$67.82 +1.3%	47.95	$575.11 million	46,858	70,106
PROK ProKidney	$2.39 +2.1%	N/A	$548.13 million	250,633	714,660	Gap Up
PRME Prime Medicine	$4.40 +0.7%	N/A	$528.14 million	406,885	772,519

More Biotech Resources

For those interested in diving deeper into the biotech sector, here are a couple of valuable resources:

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

(Ad)

The decline of Baltimore is symbolic of a financial sea-change that is unfolding all across the country… One that almost nobody else has connected the dots on, but that I believe could either enrich or impoverish millions over the next 12 to 24 months.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists:

Low Priced Stocks:

Stocks By Exchange:

Latest Stock Ideas:

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

More Biotech Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools